Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System Clinical research trials and Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System. Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System clinical trial. Subjects typically recieve the finest healthcare available for their Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System

Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System



Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System

For Condition: Immunologic Deficiency Syndromes,Neoplasms
Status: Completed
Sponsor(s): National Cancer Institute (NCI) ,
Synopsis: The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
Details: The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
Eligibility:
Study Type:
  Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Patients will be studied if a disorder of the immune system is suspected.
Total Enrollment: 9999

Location and Contact Information:

National Cancer Institute (NCI)
Bethesda,  Maryland,  20892
United States
 


Additional Information:
Study ID Numbers:
  770066;  77-C-0066
Study Start Date: April 22, 1977
Record last reviewed: April 1, 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001158

Other Immunologic Deficiency Syndromes Studies:
1. Phase I Trial of ABT-751 in Children with Solid Tumors

2. Dosing and Safety Study of E7820 in Patients with a Malignant Solid Tumor or Lymphoma

3. A Phase I Trial of 5-Flouroucacil Given with 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients with Solid Tumors

4. MG98 in Treating Patients With Advanced Solid Tumors

5. A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

Related Studies:

Other Immunologic Deficiency Syndromes Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials

Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System

Modify your Search

  Other Immunologic Deficiency Syndromes Clinical Trials
  Other Maryland Clinical Trials
  Other Bethesda Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103